Selventa Strengthens Intellectual Property for System Diagnostics (SysDx) Approach to Personalized Medicine
5/8/2013 10:57:42 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa today announced that it has been granted United States patent (No. No 8,417,661) titled “Method for Quantifying Amplitude of a Response of a Biological Network.” This patent is core to Selventa’s SysDx™ approach to mining and comparing biological data for predicting a patient’s response or non-response to a drug.
Help employers find you! Check out all the jobs and post your resume.